Association Between Twelve Polymorphisms in Five X-ray Repair Cross-complementing Genes and the Risk of Urological Neoplasms: A Systematic Review and Meta-Analysis
- PMID: 28330811
- PMCID: PMC5405151
- DOI: 10.1016/j.ebiom.2017.03.009
Association Between Twelve Polymorphisms in Five X-ray Repair Cross-complementing Genes and the Risk of Urological Neoplasms: A Systematic Review and Meta-Analysis
Abstract
Polymorphisms in X-ray repair cross-complementing (XRCC) genes have been implicated in altering the risk of various urological cancers. However, the results of reported studies are controversial. To ascertain whether polymorphisms in XRCC genes are associated with the risk of urological neoplasms, we conducted present updated meta-analysis and systematic review. Summary odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were used to estimate the association. Finally, 54 publications comprising 129 case-control studies for twelve polymorphisms in five XRCC genes were enrolled. We identified that XRCC1-rs25489 polymorphism was associated with an increased risk of urological neoplasms in heterozygote and dominant models. Moreover, in the subgroup analysis by cancer type, we found that XRCC1-rs25489 polymorphism was associated with an increased risk of bladder cancer (BC) in heterozygote model. Although overall analyses suggested a null result for XRCC1-rs25487 polymorphism, in the stratified analysis by ethnicity, an increased risk of urological neoplasms for Asians in allelic and homozygote models was identified. While for other polymorphisms in XRCC genes, no significant association was uncovered. To sum up, our results indicated that XRCC1-rs25489 polymorphism is a risk factor for urological neoplasms, particularly for BC. Further studies with large sample size are needed to validate these findings.
Keywords: Meta-analysis; Polymorphism; Risk; Urological neoplasm; XRCC.
Copyright © 2017 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. Published by Elsevier B.V. All rights reserved.
Figures


Similar articles
-
Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.Eur J Obstet Gynecol Reprod Biol. 2017 Nov;218:12-20. doi: 10.1016/j.ejogrb.2017.09.011. Epub 2017 Sep 14. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 28926725
-
X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.PLoS One. 2012;7(9):e44441. doi: 10.1371/journal.pone.0044441. Epub 2012 Sep 12. PLoS One. 2012. PMID: 22984511 Free PMC article.
-
Selenium for preventing cancer.Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4. Cochrane Database Syst Rev. 2018. PMID: 29376219 Free PMC article.
-
The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.Cancer Rep (Hoboken). 2023 Mar;6(3):e1776. doi: 10.1002/cnr2.1776. Epub 2022 Dec 27. Cancer Rep (Hoboken). 2023. PMID: 36573562 Free PMC article.
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
Cited by
-
Polymorphism of XRCC3 in Egyptian Breast Cancer Patients.Pharmgenomics Pers Med. 2020 Aug 6;13:273-282. doi: 10.2147/PGPM.S260682. eCollection 2020. Pharmgenomics Pers Med. 2020. PMID: 32821150 Free PMC article.
-
Mex3a expression and survival analysis of bladder urothelial carcinoma.Oncotarget. 2017 Jun 7;8(33):54764-54774. doi: 10.18632/oncotarget.18399. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903380 Free PMC article.
-
DNA Repair Mechanism Gene, XRCC1A ( Arg194Trp) but not XRCC3 ( Thr241Met) Polymorphism Increased the Risk of Breast Cancer in Premenopausal Females: A Case-Control Study in Northeastern Region of India.Technol Cancer Res Treat. 2017 Dec;16(6):1150-1159. doi: 10.1177/1533034617736162. Epub 2017 Nov 21. Technol Cancer Res Treat. 2017. PMID: 29332455 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources